ArticleScientific reports2026
Draft genome and physiological characterization of a newly isolated L-arabinose-utilizing Corynebacterium glutamicum CS176.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study reports the physiological and genomic characterization of Corynebacterium glutamicum CS176, a newly isolated strain exhibiting a rare combination of traits: efficient L-arabinose utilization and L-glutamate production without chemical induction, even under excess biotin conditions. Genome analysis of the 3.10 Mb draft sequence (54.20% GC) revealed a 7.8 kb L-arabinose utilization gene cluster highly similar to those of arabinose-assimilating strains, suggesting acquisition via horizontal gene transfer. To link genotype with phenotype, the effects of temperature, oxygen availability, carbon sources, and biotin concentration on bacterial growth and L-glutamate production were systematically evaluated under controlled conditions. Optimal growth was observed at 30-37 °C under high oxygen conditions, whereas maximal L-glutamate production (up to 2.5 g/L in mixed substrates) occurred at 37-39.5 °C under medium-low oxygen conditions. Notably, CS176 maintained L-glutamate production across a wide range of biotin concentrations (0-200 µg/L), in contrast to the typical biotin-dependent regulation observed in C. glutamicum. Furthermore, glucose-arabinose co-utilization enhanced both growth and L-glutamate production, highlighting metabolic flexibility. Together, these findings identify CS176 as a promising strain that overcomes key limitations in conventional glutamate fermentation and provides insights for metabolic engineering and sustainable bioprocess development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.